Wuhan Hiteck Biological Pharma Co (SZSE:300683) Price-to-Tangible-Book : 1.53 (As of Jun. 22, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co Price-to-Tangible-Book?

As of today (2024-06-22), Wuhan Hiteck Biological Pharma Co's share price is ¥22.30. Wuhan Hiteck Biological Pharma Co's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was ¥14.56. Hence, Wuhan Hiteck Biological Pharma Co's Price to Tangible Book Ratio of today is 1.53.

The historical rank and industry rank for Wuhan Hiteck Biological Pharma Co's Price-to-Tangible-Book or its related term are showing as below:

SZSE:300683' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.5 Med: 2.52 Max: 4.1
Current: 1.53

During the past 11 years, Wuhan Hiteck Biological Pharma Co's highest Price to Tangible Book Ratio was 4.10. The lowest was 1.50. And the median was 2.52.

SZSE:300683's Price-to-Tangible-Book is ranked better than
67.83% of 861 companies
in the Drug Manufacturers industry
Industry Median: 2.31 vs SZSE:300683: 1.53

A closely related ratio is called PB Ratio. As of today, Wuhan Hiteck Biological Pharma Co's share price is ¥22.30. Wuhan Hiteck Biological Pharma Co's Book Value per Sharefor the quarter that ended in Mar. 2024 was ¥18.81. Hence, Wuhan Hiteck Biological Pharma Co's P/B Ratio of today is 1.19.

Wuhan Hiteck Biological Pharma Co Price-to-Tangible-Book Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co Price-to-Tangible-Book Chart

Wuhan Hiteck Biological Pharma Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.20

3.26

3.79

2.26

2.47

Wuhan Hiteck Biological Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial															2.19	2.28	2.30	2.47	1.78

Competitive Comparison of Wuhan Hiteck Biological Pharma Co's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Wuhan Hiteck Biological Pharma Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan Hiteck Biological Pharma Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wuhan Hiteck Biological Pharma Co's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Wuhan Hiteck Biological Pharma Co's Price-to-Tangible-Book falls into.

Wuhan Hiteck Biological Pharma Co Price-to-Tangible-Book Calculation

Wuhan Hiteck Biological Pharma Co's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	22.30	/	14.56
	=	1.53

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Wuhan Hiteck Biological Pharma Co Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Wuhan Hiteck Biological Pharma Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » Price-to-Tangible-Book

Traded in Other Exchanges

N/A

Address

Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056

Website

http://www.hiteck.com.cn

Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.

Executives

Yan Jie	Director
Li Sheng Qiang	Executives

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Headlines

No Headlines